Two Sigma Investments’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.4M Sell
256,501
-9,031
-3% -$715K 0.02% 909
2025
Q4
$20.7M Sell
265,532
-164,443
-38% -$11.1M 0.03% 710
2025
Q3
$24.3M Buy
429,975
+270,812
+170% +$12.2M 0.04% 569
2025
Q2
$6.95M Buy
159,163
+11,543
+8% +$397K 0.01% 1035
2025
Q1
$4.04M Sell
147,620
-26,133
-15% -$953K 0.01% 1242
2024
Q4
$6.99M Sell
173,753
-96,282
-36% -$4.35M 0.02% 922
2024
Q3
$12.8M Sell
270,035
-78,883
-23% -$3.48M 0.03% 656
2024
Q2
$10.4M Buy
348,918
+221,172
+173% +$7.66M 0.02% 695
2024
Q1
$5.14M Sell
127,746
-4,818
-4% -$172K 0.01% 956
2023
Q4
$3.38M Sell
132,564
-94,675
-42% -$1.69M 0.01% 1200
2023
Q3
$3.16M Buy
227,239
+39,935
+21% +$803K 0.01% 1129
2023
Q2
$4.31M Sell
187,304
-55,208
-23% -$1.58M 0.01% 993
2023
Q1
$7.19M Buy
242,512
+123,465
+104% +$3.98M 0.02% 732
2022
Q4
$2.97M Sell
119,047
-10,324
-8% -$275K 0.01% 1113
2022
Q3
$2.82M Sell
129,371
-14,586
-10% -$384K 0.01% 997
2022
Q2
$2.83M Buy
143,957
+87,633
+156% +$2.05M 0.01% 1012
2022
Q1
$2.38M Buy
56,324
+49,302
+702% +$2.08M 0.01% 1271
2021
Q4
$446K Buy
+7,022
New +$409K ﹤0.01% 3359
2021
Q2
Sell
-10,665
Closed -$414K 4419
2021
Q1
$414K Buy
+10,665
New +$642K ﹤0.01% 3096

Other funds holding KYMR